Iktar informazzjoni ― Malti

Confluent and reticulated papillomatosis (CRP) , imsejjaħ ukoll sindromu Gougerot-Carteaud, jirriżulta minn tkabbir anormali taċ-ċelluli tal-ġilda. Jidher bħala tikek skuri bla tbatija li jistgħu jingħaqdu f'irqajja akbar, li ġeneralment jidhru fuq in-naħa ta 'fuq tas-sider u l-għonq ta' adoloxxenti u adulti żgħażagħ. L-għażla tat-trattament inizjali hija minocycline.
Confluent and reticulated papillomatosis (CRP), also known as Gougerot-Carteaud syndrome, is caused by disordered keratinization. It presents with asymptomatic hyperpigmented papules that can coalesce into plaques and are typically located on the upper trunk and neck of teens and young adults. First-line treatment is oral 'minocycline'.

Is-CRP ġeneralment tidher bħala tikek skuri u rqajja mingħajr sintomi fuq il-ġilda madwar l-għonq, l-armpits, il-parti ta’ fuq tas-sider u l-parti ta’ fuq tad-dahar. Xi drabi, jista 'jinfirex sa' forehead u 'l isfel sa l-erja pubika. Antibijotiċi bħal minocycline saru għażla ta' trattament preferuta.
CRP typically presents as asymptomatic hyperpigmented papules and plaques with peripheral reticulation over the nape, axillae, upper chest, and upper back, occasionally with extension superior to the forehead and inferior to the pubic region. Antibiotics, such as 'minocycline', at anti-inflammatory doses have emerged as a preferred therapeutic option.